Results 221 to 230 of about 71,029 (345)

Treatment of Chronic Myeloid Leukaemia with Mercaptopurine [PDF]

, 1956
James R. Fountain
openalex   +1 more source

The Global Burden of Leukemia, 1990–2021: A Systematic Analysis of Prevalence, DALYs, and Risk Factors From the Global Burden of Disease Study

Med Research, EarlyView.
Using data from the Global Burden of Disease Study 2021, we systematically assessed leukemia prevalence and disability‐adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021, stratified by subtype, demographics, and risk factors.
Yuping Wu, Haini Zhang, Shuang Luo, Xiangmei Zhang, Mei Tan, Jinmei Chen, Pei Huang, Yan Chen, Zuochen Du   +8 more
wiley   +1 more source

Incidental apical left ventricular mural thrombus late after myocardial infarction with chronic myeloid leukaemia detected by cardiac magnetic resonance: a case report. [PDF]

Eur Heart J Case Rep
Nguyen QM, Almoosa F, Choong MCM, Elsmaan M, Alpendurada FD.   +4 more
europepmc   +1 more source

Chronic myeloid leukaemia

, 2019
Francis Deng, Joshua Yap, Yuranga Weerakkody   +2 more
openaire   +1 more source

Machine Learning for Predictive Modeling in Nanomedicine‐Based Cancer Drug Delivery

Med Research, EarlyView.
The integration of AI/ML into nanomedicine offers a transformative approach to therapeutic design and optimization. Unlike conventional empirical methods, AI/ML models (such as classification, regression, and neural networks) enable the analysis of complex clinical and formulation datasets to predict optimal nanoparticle characteristics and therapeutic
Rohan Chand Sahu, Sanchit Arora, Dinesh Kumar, Ashish Kumar Agrawal   +3 more
wiley   +1 more source

Is there really an accelerated phase of chronic myeloid leukaemia at presentation? [PDF]

Leukemia
Yang S, Zhang X, Gale RP, Huang X, Jiang Q.   +4 more
europepmc   +1 more source

CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling

Med Research, EarlyView.
CRISPR technology has progressed from a prokaryotic immune system to a diverse suite of editing platforms, including Cas nucleases, base and prime editors, and RNA‐targeting enzymes. These advances enable precise genomic and epigenomic interventions, high‐throughput functional screening, and immune engineering.
Kailai Li, Peixin Huang, Yue Qian, Anqi Lin, Jingjun He, Junyi Shen, Li Chen, Kai Miao, Jian Zhang   +8 more
wiley   +1 more source

Secondary malignancies after chronic myeloid leukaemia upon TKI treatment: Population trends and outcomes. [PDF]

Br J Haematol
Zu Y, Yue X, Zhan X, Liu X, Ma H, Qin F, Duan L, Zhao H, Zhang Y, He S, Zhao H, Zhang C, Xin X, Zhang W, Song Y, Liu B, Li W, Zhang Y.   +17 more
europepmc   +1 more source

Leukemia in Older Adults: Global, National, and Regional Disease Burden Patterns During 1990–2019 and Forecasted Trends to 2030

Medicine Advances, EarlyView.
After analyzing the burden of leukemia in the elderly aged 60–89 years from 1990 to 2019 using the Global Burden of Disease database, we found that although the burden of chronic myeloid leukemia has decreased over the past 30 years, the burden of other types of leukemia has continued to increase to varying degrees.
Jing Wei, Qijian Feng, Ziyuan Lu
wiley   +1 more source

Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia: Predisposing and driving alterations. [PDF]

Br J Haematol
Behrens YL, Reinkens T, Hofmann W, Gumann A, Förster A, Gaschler L, Ghete T, Strasser R, Espenkötter J, Haermeyer B, Losch M, Sembill S, Wotschofsky Z, von Hörsten S, Schuh W, Di Donato N, Suttorp M, Krumbholz M, Ripperger T, Schlegelberger B, Göhring G, Metzler M, Karow A.   +22 more
europepmc   +1 more source